Anti-Infective Strategies of the Future: Is there Room for Species-Specific Antibacterial Agents?
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
555-566
Author(s):
Rudolf L. Then and Hans-Georg Sahl
The Expanding Universe of Neurotrophic Factors: Therapeutic Potential in Aging and Age-Associated Disorders
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
698-717
Author(s):
C. Lanni, S. Stanga, M. Racchi and S. Govoni
Antiphospholipid Syndrome as a Neurological Disease
Journal:
Current Rheumatology Reviews
Volume:
6
Page:
12-17
Author(s):
Carlos Ewerton Maia Rodrigues, Jozelio Freire Carvalho and Yehuda Shoenfeld
Circumventing Immune Tolerance Through Epigenetic Modification
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
268-276
Author(s):
Jason A. Dubovsky, Alejandro Villagra, John J. Powers, Hong-Wei Wang, Javier Pinilla-Ibarz and Eduardo M. Sotomayor
Recent Patents on Novel P2X7 Receptor Antagonists and their Potential for Reducing Central Nervous System Inflammation
Journal:
Recent Patents on CNS Drug Discovery (Discontinued)
Volume:
5
Page:
35-45
Author(s):
Scott A. Friedle, Marjorie A. Curet and Jyoti J. Watters
Small Ruminant Lentiviruses and Human Immunodeficiency Virus: Cousins that Take a Long View
Journal:
Current HIV Research
Volume:
8
Page:
26-52
Author(s):
Barbara A. Blacklaws and Gordon D. Harkiss
CD44 - a New Cardiovascular Drug Target or Merely an Innocent Bystander?
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
9
Page:
293-302
Author(s):
Alexandra Krettek and Sara Sjoberg
The Yin and Yang of CD4+ Regulatory T Cells in Autoimmunity and Cancer
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4626-4631
Author(s):
M. Galgani, A. Di Giacomo, G. Matarese and A. La Cava
Monoclonal Antibodies in the Treatment of Multiple Sclerosis
Journal:
Current Medicinal Chemistry
Volume:
16
Page:
4858-4868
Author(s):
F. Di Pauli, T. Berger and M. Reindl
Immune Cell Entry to Central Nervous System - Current Understanding and Prospective Therapeutic Targets
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
9
Page:
315-327
Author(s):
Catriona T. Prendergast and Stephen M. Anderton